MetLife Company Profile (NYSE:MET)

MetLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

MetLife declared a quarterly dividend on Friday, July 7th. Investors of record on Monday, August 7th will be given a dividend of $0.40 per share on Wednesday, September 13th. This represents a $1.60 annualized dividend and a yield of 2.92%. The ex-dividend date is Thursday, August 3rd. View MetLife's Dividend History.

MetLife, Inc. (NYSE:MET) released its quarterly earnings results on Wednesday, May, 3rd. The company reported $1.46 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.27 by $0.19. The company had revenue of $16.27 billion for the quarter, compared to analyst estimates of $17.02 billion. MetLife had a positive return on equity of 7.57% and a negative net margin of 0.95%. The company's revenue was down 11.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.20 EPS. View MetLife's Earnings History.

10 brokerages have issued 12-month price targets for MetLife's stock. Their forecasts range from $51.00 to $78.00. On average, they anticipate MetLife's share price to reach $59.65 in the next twelve months. View Analyst Ratings for MetLife.

Here are some recent quotes from research analysts about MetLife stock:

• 1. According to Zacks Investment Research, "MetLife’s earnings of $1.46 per share beat the Zacks Consensus Estimate by 14.96% and were up 12.3% year over year. Earnings benefited from volume growth, continued expense discipline and higher fees from improved equity markets. MetLife’s consistent growth via acquisitions and divestitures allow it to focus on core business. The separation of the company’s retail unit will reduce its risk exposure to equity and interest rates. Its efforts to reduce expenses will cushion its bottom line in the long term. A strong balance sheet, improved cash balance and low debt level are other positives. The stock has, outperformed the Zacks categorized Multi Line Insurance industry over the past one year. MetLife, nevertheless, remains exposed to headwinds like still low interest rates, adverse foreign exchange, taxes, regulatory uncertainty surrounding its SIFI designation, and stiff competition." (5/5/2017)
• 2. Wells Fargo & Company analysts commented, "We sensed expectations among investors were low for MET going into Q1 earnings, and in our view the quarter at least met those expectations, with the majority of the outperformance relative to our expectation occurring in MetLife Holdings and the Corporate segment. We knew there was some re-positioning of hedging strategies going on in the quarter to make the derivative portfolio more “statutory-friendly” so we are not overly concerned with the net derivative losses (assuming they did not lower statutory capital levels, which will be discussed on the conference call on May 4). As we move toward the spin of Brighthouse, we can see the evolution of RemainCo MetLife’s less volatile earnings profile, which we believe will be rewarded with higher multiples over time." (5/4/2017)

Some companies that are related to MetLife include Prudential Public Limited Company (PUK), Prudential Financial (PRU), Prudential plc (PRU), Manulife Financial Corp (MFC), Aflac Incorporated (AFL), Sun Life Financial (SLF), Aviva plc (AV), Principal Financial Group (PFG), Lincoln National Corporation (LNC), Aegon NV (AEG), Unum Group (UNM), Athene Holding (ATH), Standard Life Plc (SL), Voya Financial (VOYA), StanCorp Financial Group (SFG), CNO Financial Group (CNO), Symetra Financial (SYA) and Phoenix Group Holdings (PHNX).

MetLife's management team includes the folowing people:

• Steven A. Kandarian J.D., Chairman of the Board, President, Chief Executive Officer
• John C. R. Hele, Chief Financial Officer, Executive Vice President
• Michel Khalaf, President, EMEA
• Christopher G. Townsend, President, Asia
• Susan Podlogar, Chief Human Resource Officer, Executive Vice President
• William O'Donnell, Executive Vice President, Chief Accounting Officer
• Steven J. Goulart, Executive Vice President, Chief Investment Officer
• Esther Lee, Executive Vice President, Global Chief Marketing Officer
• Ricardo A. Anzaldua J.D., Executive Vice President, General Counsel
• Martin J. Lippert, Executive Vice President, Head - Global Technology and Operations

MetLife's stock is owned by many different of institutional and retail investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (14.90%), Diamond Hill Capital Management Inc. (0.65%), APG Asset Management N.V. (0.36%), NN Investment Partners Holdings N.V. (0.29%), Acadian Asset Management LLC (0.22%) and Jarislowsky Fraser Ltd (0.21%). Company insiders that own MetLife stock include Frans Hijkoop, James M Kilts, Kenton J Sicchitano, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for MetLife.

MetLife's stock was sold by a variety of institutional investors in the last quarter, including Strs Ohio, DnB Asset Management AS, Sit Investment Associates Inc., Russell Investments Group Ltd., Jarislowsky Fraser Ltd, BB&T Corp, Exxonmobil Investment Management Inc. TX and ING Groep NV. Company insiders that have sold MetLife stock in the last year include Frans Hijkoop, Maria R Morris and Peter M Carlson. View Insider Buying and Selling for MetLife.

MetLife's stock was acquired by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, NN Investment Partners Holdings N.V., Hexavest Inc., Diamond Hill Capital Management Inc., Mn Services Vermogensbeheer B.V., Gradient Investments LLC, Oakbrook Investments LLC and National Pension Service. View Insider Buying and Selling for MetLife.

Shares of MetLife can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MetLife stock can currently be purchased for approximately $54.73.